Enzo Biochem Announces Ransomware Attack Resulted in Data Breach Impacting Nearly 2.5 Million Consumers | Console and Associates, P.C. | #hacking | #cybersecurity | #infosec | #comptia | #pentest | #ransomware

On May 30, 2023, Enzo Biochem, Inc. filed documents with the Securities and Exchange Commission announcing that the company experienced a ransomware attack resulting in millions of patients’ information being compromised. Based on the company’s official filing, the incident resulted in an unauthorized party gaining access to consumers’ names, Social Security numbers and clinical test information. Once the company’s investigation is complete and it confirms consumer data was leaked, Enzo will begin sending out data breach notification letters to all individuals who were impacted by the recent data security incident.

If you received a data breach notification from Enzo Biochem, it is essential you understand what is at risk and what you can do about it. To learn more about how to protect yourself from becoming a victim of fraud or identity theft and what your legal options are in the wake of the Enzo Biochem data breach, please see our recent piece on the topic here.

What We Know So Far About the Enzo Biochem Breach

News of the Enzo Biochem data breach is still fresh; however, what we know at this point comes from the company’s filing with the Securities and Exchange Commission. According to this source, on April 6, 2023, Enzo learned that it was the target of a ransomware attack targeting the company’s IT network. In response, Enzo Biochem secured its system, disconnected its devices from the network, notified law enforcement and then launched an investigation into the incident with the assistance of third-party cybersecurity experts.

On April 11, 2023, the Enzo Biochem investigation confirmed that hackers were able to access and remove certain data from the company’s computer network. It was later determined that some of the files that were accessible to the hackers contained confidential consumer information.

Upon discovering that sensitive consumer data was made available to an unauthorized party, Enzo Biochem began to review the affected files to determine what information was compromised and which consumers were impacted. While the breached information varies depending on the individual, it may include your name, clinical test information and Social Security number. In total, the Enzo data breach affected 2,470,000 million people. The company reports that 600,000 unique Social Security numbers were included in that figure.

On May 30, 2023, Enzo Biochem notified the Securities and Exchange Commission. In this notice, Enzo explains that it will be sending out data breach letters to all individuals whose information was compromised as a result of the recent data security incident.

More Information About Enzo Biochem

Founded in 1976, Enzo Biochem is a life sciences and biotechnology company based in New York, New York. The company owns three subsidiaries, Enzo Therapeutics, Enzo Life Sciences, and Enzo Clinical Labs. Enzo Clinical Labs, Inc. provides diagnostic testing directly to patients. Enzo Diagnostics develops and markets probe-based DNA tests to assist in detecting viral and bacterial diseases. Enzo Therapeutics uses licensed antisense nucleic acid technology to find cures for cancer and other diseases. Together, Enzo Biochem employs more than 450 people and generates approximately $111 million in annual revenue.


Click Here For The Original Source.

National Cyber Security